It has been predicted that 1985 will have seen a total spending on alcoholic beverages in the UK of £9 000 000 0001. It is a relatively simple task to calculate that of this staggering sum around £3500000000 will be paid to the government as revenue. Much more difficult, however, is the calculation of the cost to the country of the harmful effects of drinking. Estimates run at around £1 000 000 000, but it is impossible to state these with any confidence, largely because of the extent to which alcohol problems remain undetected. Screening for patients at risk because of their drinking has been shown to identify large numbers of previously undetected cases in the community2 and proportionately more in hospital populations3. There isnow some evidence from a recent study in Edinburgh that in the case of the latter a single session of counselling about their drinking during admission to the medical wards can significantly improve outcome at one year4. On the basis of such evidence, a rationale emerges for a policy of systematic screening for patients at risk because of their drinking, so that advice can be given before irreversible physical or psychosocial problems develop.
In their paper in this issue of the JRSM (p 132), Lockhart and colleagues add to the growing evidence that alcohol is an important contributory factor in a large proportion of acute admissions to hospital. In line with a number of earlier studies, their results indicate that more than one-quarter of both male and female acute admissions to the general medical wards, in this case in an inner London district general hospital, result directly or indirectly from excessive alcohol consumption. Very nearly two-thirds of these patients do not -present with any of the classical features of alcohol-related illness, and would therefore be likely to remain undetected as being at risk from their drinking in the absence of a policy of active identification.
How can such a policy best be carried out? The studies which have attempted to answer this question have all faced methodological problems which unfortunately continue to hamper this area of research. First of all, what constitutes a level of alcohol consumption at which -patients can be deemed to be at risk from their drinking? The answer remains controversial, largely-because ofthe paucity of reliable data relating different levels of alcohol consumption to ill health. Until satisfactory, standardized and objective measures of assessing alcohol consumption can be developed, it seems inevitable that this issue will remain unresolved. Some hope exists in the form of an assay of a haemoglobin-acetaldehyde complex which would provide a measure of long-term alcohol consumption in a manner analogous to that in which glycosylated haemoglobin is used in monitoring diabetic control. However, perfection of this technique still seems some way off. Secondly, what measure can be used as a 'gold standard' against which to evaluate different methods of identification of patients at risk from their drinking? Unfortunately, here too there are serious methodological flaws, again largely because of the lack of a reliable objective measure of consumption. The result is that efforts at evaluation can seem curiously circular. The study by Lockhart and colleagues is no exception, for in the final analysis their conclusion would appear to be that the best indicator that a house officer was correct in relating a patient's admission to his alcohol consumption was the house officer's clinical suspicion that this was the case! Yet despite the absence of a satisfactory 'gold standard', the findings of studies to evaluate methods of screening have been remarkably consistent5 7
There is now little doubt that. for the purposes of screening, questioning about alcohol consumption is superior to the use of laboratory tests such as mean corpuscular volume and gamma-glutamyl transferase. Clinical suspicion should remain paramount, with laboratory tests regarded-as a back-up and as an illustration to patients of the objective evidence that drinking is already damaging their health. Detailed enquiry into alcohol consumption by means either of a quantity/frequency scale or a detailed history of the past week's drinking should be adopted as a routine part of medical assessment. A screening procedure of-this kind is simple and inexpensive. Not only can it increase the identification of patients at risk because of their drinking, but it may also encourage physicians to give patients advice. Although further evaluation is required, this approach appears to hold considerable promise for the prevention of irreversible physical and psychosocial drink-related problems, and thus perhaps for a substantial saving of the exchequer. 1985;290:1949-53 Neurological dysfunction following coronary artery bypass graft surgery Current enthusiasm for coronary artery bypass graft (CABG) surgery is well justified in terms of both the relief of angina, and prolongation of life expectancy in some subgroups of patients. Improvements in technique have resulted in a steady decline in the risks of the procedure and, in good centres, mortality rates below 2% are the rule. This combination of enthusiasm and decreasing risk has contributed to a continuing rise in the number of operations performed, associated with a tendency for CABG to be offered to patients with milder degrees of coronary artery disease.
Since the advent of open heart surgery, serious neurological morbidity has been recognized, and CABG surgery has not been spared. Recent studies from Newcastle upon Tyne', and from the Cleveland Clinic, Ohio2, have reported incidences of fatal cerebral injury of 0.3% and 0.7% respectively. The overall incidence of postoperative neurological morbidity reported in the Newcastle study was 61%. Many studies have shown lesser degrees of morbidity but all are open to criticisms of technique. Most are retrospective, with assessment performed by non-neurologically trained investigators and the timing of assessments being less than optimum. Many are merely retrospective reviews of case notes. These studies will detect overt morbidity such as major stroke but are of no value in defining more subtle neurological dysfunction.
What, then, is the true incidence of CABG-related neurological morbidity? From recent prospective studies a picture of the incidence and spectrum of neurological morbidity emerges. The Cleveland Clinic study2 included 418 patients, 30% of whom developed neurological complications. The Newcastle study included 312 patients with an incidence of 61%, as quoted above. This latter study included neuropsychological evaluation, demonstrating immediate postoperative impairment in 79%/ of patients tested3. The clinical spectrum of neurological disorders described affects all levels of the nervous system.
Disturbance of conscious level ranging from protracted somnolence to frank coma was found in 3%1l.
Postoperative coma is especially sinister, carrying a high probability of death or serious neurological sequelae4. Perioperative stroke was found in 4.8% 1 and 5.2%2 and resulted in permanent neurological disability in 1.3% and 2% respectively. Visual symptoms are common after CABG and detectable ophthalmological signs occurred in 25% in the Newcastle study, including retinal infarcts and emboli, visual field defects and unexplained reduction in visual acuity. Rarer central nervous system (CNS) complications reported in the literature include postoperative seizures and spinal cord infarction. Neurological signs detected in the absence of clinical disability include isolated extensor plantar responses, and the development of primitive reflexes. These latter clinical signs are of great interest and probably indicate that minor subclinical cerebral injury is very common.
Peripheral nervous system damage is not uncommon. Brachial plexus damage occurs in about 7% of patients'. Other peripheral complications include damage to the phrenic, ulnar, median, common peroneal, lateral femoral cutaneous, saphenous and facial nerves. Sympathetic damage resulting in Homer's syndrome may also occur.
The neuropsychological morbidity described in 30% of patients by Savageau et al.6 and in 79% in the Newcastle study3 appears to result from cardiopulmonary bypass rather than a nonspecific effect of major surgery. Whilst there is evidence that this neuropsychological impairment commonly recovers satisfactorily within 6 months, the impact on patients' lives of early cognitive changes and of psychiatric disturbances after CABG may be greater than is generally appreciated. Impairment of new learning ability, psychomotor speed, concentration, and short-term memory are the most frequently detected cognitive changes. The clinical significance of this catalogue of neurological and neuropsychological morbidity should not be overestimated. Death or disabling stroke are infrequent and the potential benefit of CABG surgery to patients incapacitated by angina clearly outweighs the risk. Approximately 8% of patients in the Newcastle study had important neurological disability at the time of their discharge from hospital. However, lesser degrees of functionally significant damage are worrying to patients and their relatives. Experience suggests that these minor problems are usually undiagnosed on busy postsurgical wards. Much of this morbidity resolves rapidly, and severe neurological disability persisting at six months after surgery is infrequent.
In view of the incidence and natural history of this morbidity, what should preoperative patients and their relatives be told by their doctor about the risks of CABG? It would seem reasonable to advise the patient that minor transient disturbances of vision, memory and concentration are common in the postoperative period but may be expected to resolve. There is a much lesser risk of stroke occurring and the incidence of stroke with serious permanent disability is slight. From the point of view of doctors participating in the postoperative care, there is clearly no need for detailed neurological examination in every case to detect functionally insignificant signs. They should, however, be aware 0141-0768/86 030130-02/$02.00/0 0 1986 The Royal Society of Medicine
